Ng, A., Chan, E. W., Huang, D., Lam, C. C., Tan, N., Siu, C. W., . . . Yan, B. P. Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A randomised, open-label study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationNg, Andrew, et al. Protocol, Rationale and Design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A Randomised, Open-label Study. BMJ Publishing Group.
MLA (9th ed.) CitationNg, Andrew, et al. Protocol, Rationale and Design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A Randomised, Open-label Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.